Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin–angiotensin–aldosterone system activity and the efficacy of renin–angiotensin–aldosterone system blockade in the kidney

Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial

(2010) F. Persson et al.   DIABETOLOGIA

Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study)

(2010) Hiroyuki Kobori et al.   JOURNAL OF HYPERTENSION

Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy

(2010) A. Nishiyama et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

(2009) F. Persson et al.   DIABETES CARE

Aliskiren-Binding Increases the Half Life of Renin and Prorenin in Rat Aortic Vascular Smooth Muscle Cells

(2008) Wendy W. Batenburg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans

(2008) Naomi D.L. Fisher et al.   CIRCULATION

Aliskiren Accumulates in Renin Secretory Granules and Binds Plasma Prorenin

(2008) Manne Krop et al.   HYPERTENSION

The Collecting Duct Is the Major Source of Prorenin in Diabetes

(2008) Jung J. Kang et al.   HYPERTENSION

Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients

(2008) Hiroyuki Kobori et al.   HYPERTENSION